Innovation1 Biotech Inc.

IVBT

US39809D2018

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 07:01:07 19/04/2024 pm IST			5-day change	1st Jan Change
0.0008 ^USD	-96.36%		-.--%	-99.07%

17/01	Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	CI
2023	Innovation1 Biotech Inc. announced that it has received $0.15 million in funding	CI

Innovation1 Biotech Inc. Announces Resignation of Jeffrey Kraws as a Director

April 24, 2023 at 03:50 pm IST

Innovation1 Biotech Inc. announced that on April 21, 2023, Jeffrey Kraws submitted to the Board of Directors of the Company, a notice of resignation from his position as a director of the Company, with such resignation to be effective immediately.

Latest news about Innovation1 Biotech Inc.

Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	17/01	CI
Innovation1 Biotech Inc. announced that it has received $0.15 million in funding	06/12	CI
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding	01/11	CI
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding	11/23/11	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	13/23/13	CI
Innovation1 Biotech Inc. announced that it has received $0.066891 million in funding	01/23/01	CI
Innovation1 Biotech Inc. Announces Resignation of Patrick Morris as Chairman of the Board	12/23/12	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	31/23/31	CI
Innovation1 Biotech Inc. Announces Resignation of Jeffrey Kraws as a Director	24/23/24	CI
Innovation1 Biotech Inc. announced that it expects to receive $0.28 million in funding from Cavalry Fund I Management, LLC, Lincoln Park Capital, LLC, L1 Capital Pty. Limited	13/23/13	CI
Innovation1 Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	18/23/18	CI
Innovation1 Biotech Inc. announced that it has received $0.3 million in funding from Cavalry Fund I Management, LLC, L1 Capital Pty. Limited, Lincoln Park Capital, LLC	27/22/27	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	15/22/15	CI
Innovation1 Biotech Inc. Auditor Raises 'Going Concern' Doubt	15/22/15	CI
Innovation1 Biotech Inc. Announces Board Appointments	12/22/12	CI
Innovation1 Biotech Inc. announced that it expects to receive $0.3 million in funding from Cavalry Fund I Management, LLC, L1 Capital Pty. Limited, Lincoln Park Capital, LLC	29/22/29	CI
Innovation1 Biotech Inc. Announces the Resignation of Andrew Salzman as Chief Science Officer	18/22/18	CI
Ingenius Biotech S.L. acquired All Of The Assets Relating to Mioxal from Innovation1 Biotech Inc. for $0.1 million.	14/22/14	CI
Innovation1 Biotech Inc. Announces Resignation of Andrew Salzman	26/22/26	CI
Innovation1 Biotech Inc. Appoints Frederick E. Pierce, Ii to Its Board of Directors	15/22/15	CI
Innovation1 Biotech Inc. Announces Filing of Patent Application for Novel Combination Therapy Targeting Addiction	18/22/18	CI
Innovation1 Biotech Inc. Appoints Andrew L. Salzman, M.D., to Its Board of Directors	11/22/11	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2022	15/22/15	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2022	15/22/15	CI
Innovation1 Biotech, Inc. Announces Director Changes	08/22/08	CI

Chart Innovation1 Biotech Inc.

Duration

Period

More charts

Company Profile

Innovation1 Biotech Inc. is a shell company. The Company has no operations and is evaluating a number of strategic alternatives including, but not limited to, seeking to acquire a new business in the United States, including potentially by means of a reverse merger with an operating entity. The Company has no sources of revenue.

Sector

Investment Holding Companies

More about the company

Income Statement Evolution

More financial data

Sector Shell Companies

	1st Jan change	Capi.
INNOVATION1 BIOTECH INC.	-99.07%	17.98T
SCREAMING EAGLE ACQUISITION CORP.	-3.96%	104.44Cr
OKLO INC.	-7.48%	103.17Cr
CHURCHILL CAPITAL CORP VII	+2.10%	98Cr
APPLE ISPORTS GROUP, INC.	+41.91%	87Cr
PERELLA WEINBERG PARTNERS	+22.32%	81Cr
E7 GROUP	+8.62%	67Cr
ARES ACQUISITION CORPORATION II	+1.77%	66Cr
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	60Cr
ADMIRAL ACQUISITION LIMITED	+3.61%	50Cr

Shell Companies